Portfolio company
Swaza
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops nanofluid breathing aids and oxygen-enriched biomaterials for patients suffering from respiratory distress, chronic lung diseases, and severe wounds.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nebu-Flow
The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.
Softhale
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
NuVox Pharma
This clinical-stage biotechnology company develops oxygen therapeutics to treat hypoxia in patients at comprehensive centres for oncology, stroke and respiratory care.
Onya
This biotechnology company develops advanced therapies and medical dressings to treat chronic and acute wounds for patients with delayed healing.
Swarm Oncology
This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.
Kither Biotech
This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.
Respira
This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.
Activaero
The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.
